Russell Investments Group, Ltd. Atea Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 1,102 shares of AVIR stock, worth $3,482. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,102

Previous 504 118.65%

Holding current value

$3,482

Previous $1,000 200.0%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.17 - $4.02 $1,895 - $2,403	598 Added 118.65%	1,102 $3,000
Q2 2024 Aug 08, 2024	SELL	$3.31 - $4.04 $562 - $686	-170 Reduced 25.22%	504 $1,000
Q1 2024 May 08, 2024	SELL	$3.09 - $4.56 $13,089 - $19,316	-4,236 Reduced 86.27%	674 $2,000
Q4 2023 Feb 05, 2024	BUY	$2.8 - $3.35 $674 - $807	241 Added 5.16%	4,910 $14,000
Q3 2023 Nov 13, 2023	BUY	$3.0 - $3.79 $483 - $610	161 Added 3.57%	4,669 $14,000
Q1 2023 May 09, 2023	SELL	$3.0 - $4.97 $37,500 - $62,125	-12,500 Reduced 73.49%	4,508 $15,000
Q4 2022 Feb 08, 2023	BUY	$4.35 - $6.17 $54,374 - $77,125	12,500 Added 277.28%	17,008 $81,000
Q3 2022 Nov 04, 2022	BUY	$5.49 - $8.79 $4,968 - $7,954	905 Added 25.12%	4,508 $25,000
Q2 2022 Jul 29, 2022	SELL	$5.33 - $8.18 $31,654 - $48,581	-5,939 Reduced 62.24%	3,603 $26,000
Q1 2022 May 05, 2022	SELL	$5.5 - $9.19 $854,810 - $1.43 Million	-155,420 Reduced 94.22%	9,542 $67,000
Q4 2021 Jan 21, 2022	BUY	$7.67 - $44.59 $172,176 - $1 Million	22,448 Added 15.75%	164,962 $1.48 Million
Q3 2021 Nov 08, 2021	BUY	$21.33 - $35.06 $3 Million - $4.94 Million	140,818 Added 8302.95%	142,514 $4.93 Million
Q2 2021 Aug 04, 2021	BUY	$19.22 - $59.08 $32,597 - $100,199	1,696 New	1,696 $41,000

Others Institutions Holding AVIR

# of Institutions

112

Shares Held

52.4M

Call Options Held

900

Put Options Held

126K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $263M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Atea Pharmaceuticals, Inc. Transaction History